PCM
VCYT icon

Penserra Capital Management’s Veracyte VCYT Stock Holding History

Penserra Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,615
Closed -$75K – 1557
2021
Q3 		$75K Buy
1,615
+85
+6% +$3.71K ﹤0.01% 924
2021
Q2 		$61K Buy
1,530
+15
+1% +$641 ﹤0.01% 945
2021
Q1 		$81K Buy
1,515
+185
+14% +$10.7K ﹤0.01% 724
2020
Q4 		$65K Buy
1,330
+846
+175% +$39.2K ﹤0.01% 654
2020
Q3 		$15K Buy
+484
New +$15.4K ﹤0.01% 772

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Penserra Capital Management's VCYT Position: Q4 2021 in Review

Penserra Capital Management sold out of Veracyte (VCYT) in Q4 2021, closing a stake of 1,615 shares — an estimated $75K sold.

Penserra Capital Management first reported a position in VCYT in Q3 2020 and held it in 5 quarters. The position peaked at $81K in Q1 2021. 217 funds tracked by Wall St. Rank hold VCYT as of Q4 2021.

  • Penserra Capital Management reported no remaining Veracyte position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,615 Veracyte shares in Q4 2021, an estimated $75K.
  • Penserra Capital Management first reported a position in Veracyte in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Veracyte position peaked at $81K in Q1 2021.
  • 217 funds tracked by Wall St. Rank held Veracyte as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.